Device Week, April 10, 2019 – Alcon Is Finally Free From Novartis; EOS Promotes 3D Ortho-Imaging At AAOS
In this edition of Device Week, Catherine Longworth reports on eye-care giant Alcon's $28bn spin-off from Novartis. Marion Webb reviews her interview with executives from EOS imaging SA, a developer of imaging medical devices for orthopedics.
Listen to the podcast via the player below:
Medtech Insight articles addressing topics discussed in this episode: